Results 161 to 170 of about 42,977 (292)
Morphological Sinus Features and Chronic Rhinosinusitis Risk: A Radiomics Study
ABSTRACT Objectives Anatomical factors of the sinuses significantly impact the progression of chronic rhinosinusitis (CRS). This study aims to investigate the correlation between morphological sinus features and the risk of CRS onset to provide evidence‐based support for clinical management.
Song Luo +4 more
wiley +1 more source
Wei Wei,1,2,* Fei Xia,3,* Wang Zhou,1,* Wenwu Lu,1 Di Zhang,1 Qianqing Ma,2 Xiangyi Xu,1 Chaoxue Zhang1 1Department of Ultrasound, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, People’s Republic of China;
Ma Q +7 more
core
Yiyan Shang,1,2,* Yunxia Wang,1,2,* Yaxin Guo,2,3 Shunian Li,2,3 Jun Liao,2,3 Menglu Hai,4 Meiyun Wang,2,3 Hongna Tan1,2 1Department of Radiology, People’s Hospital of Henan University, Zhengzhou, Henan, People’s Republic of China; 2Department of
Liao J +7 more
core
Lung V5 and the planning target volume/lung volume ratio were identified as independent dosimetric risk factors for clinically significant radiation pneumonitis following moderately hypofractionated radiotherapy for lung cancer. Maintaining V5 < 35% may help mitigate this risk in clinical practice.
YuanYou Yang +3 more
wiley +1 more source
ABSTRACT Background Pathological complete response (pCR) following neoadjuvant chemoradiotherapy (nCRT) in locally advanced rectal cancer (LARC) is a key prognostic marker with implications for response‐adapted management. Although magnetic resonance imaging (MRI) is central to response assessment, differentiating residual tumour from treatment‐related
Winnie Lay +4 more
wiley +1 more source
Objective: Breast cancer clinical stage and nodal status are the most clinically significant drivers of patient management, in combination with other pathological biomarkers, such as estrogen receptor (ER), progesterone receptor or human epidermal growth
Basak E. Dogan +4 more
core +1 more source
Summary Follicular lymphoma (FL) first‐line chemoimmunotherapy yields high efficacy but serious toxicity in 65% of patients. In high tumour burden treatment‐naïve FL, we aimed to exploit known immunostimulatory and cytotoxic properties of combination checkpoint inhibition (atezolizumab) and obinutuzumab (6 cycles) with positron emission tomography (PET)
Arina Martynchyk +15 more
wiley +1 more source
Oligoprogressive renal cell carcinoma: What is the role of surgery?
Objective To provide an overview of the biological mechanism and pattern of oligoprogression in renal cell carcinoma (RCC) and the most updated role of surgery in this setting, highlighting scientific gaps and informing future implications. Methods A non‐systematic search of PubMed/MEDLINE was performed in August 2025 including guidelines, reviews, and
Chiara Re +9 more
wiley +1 more source
New concepts, innovations and some issues have emerged since the adoption a decade ago of WHO/ISUP grading for CCRCC and PRCC. Continued use of the WHO/ISUP grading for CCRCC and PRCC has been upheld by newer studies, and practice guidance for some of the grading issues, where data are available, is provided.
Gladell P. Paner +4 more
wiley +1 more source
ABSTRACT Background Accurate pretreatment assessment of the extent of tumor invasion and status of cervical lymph node metastasis is essential for staging and treatment planning in HNSCC. Deep learning (DL) shows promise but is limited by methodological heterogeneity. Methods We conducted a systematic review and network meta‐analysis (PRISMA). Studies (
Jannik Ketschau +10 more
wiley +1 more source

